Assess whether earnings quality supports the bid price (74cfce)
August 31, 2026 · SmartSolo
Situation
Buy-side QoE lead owns earnings quality supports the inside a health-system acquiring a specialty practice with customer concentration and termination-for-convenience clauses as the only packet. IT diligence showing two ERPs and no chart of accounts map is what changed the clock for this M&A Due Diligence Legal, IP, and Regulatory file.
Decision
Buy-side QoE lead in a health-system acquiring a specialty practice must choose Proceed / Reprice / Walk / Hold using customer concentration and termination-for-convenience clauses after IT diligence showing two ERPs and no chart of accounts map.
Hypotheses to test
- The population in customer concentration and termination-for-convenience clauses is the one IT diligence showing two ERPs and no chart of accounts map named, so Proceed follows for this Legal, IP, and Regulatory file.
- The population in customer concentration and termination-for-convenience clauses is adjacent only to IT diligence showing two ERPs and no chart of accounts map; Reprice is the honest M&A Due Diligence call.
- A health-system acquiring a specialty practice already contained IT diligence showing two ERPs and no chart of accounts map before customer concentration and termination-for-convenience clauses arrived; no new Legal, IP, and Regulatory path.
- Provenance on customer concentration and termination-for-convenience clauses after IT diligence showing two ERPs and no chart of accounts map is broken; do not pick Proceed or Reprice yet.
Analysis required
- Separate a one-off add-back from a recurring earnings issue in customer concentration and termination-for-convenience clauses.
- Map reps, earnout mechanics, and integration risk a health-system acquiring a specialty practice would inherit.
- Tie quality-of-earnings, working-capital, and contingent items in customer concentration and termination-for-convenience clauses to earnings quality supports the.
- For this M&A Due Diligence Legal, IP, and Regulatory file, read customer concentration and termination-for-convenience clauses against IT diligence showing two ERPs and no chart of accounts map and write the one fact that would move earnings quality supports the for buy-side QoE lead.
Recommendation
Choose Proceed / Reprice / Walk / Hold on this M&A Due Diligence / Legal, IP, and Regulatory packet (customer concentration and termination-for-convenience clauses after IT diligence showing two ERPs and no chart of accounts map). The follow-on Legal, IP, and Regulatory action is what buy-side QoE lead does next: implement the option, assign an owner, and log the missing fact.
Explore more
More M&A Due Diligence prompts
- Assess whether integration costs were sandbagged in the CIM (6708b3)
- Assess whether working capital should be a walk-away (8f4f75)
- Assess whether regulatory approval is a timing risk or a deal risk (2f208a)
- Assess whether earnout definitions will cause a post-close fight (a1f816)
- Assess whether working capital should be a walk-away (72ea75)
Explore related decision areas
- Assess whether telematics improvements offset driver quality (e89d2f)Insurance Underwriting
- Assess whether related-party revenue is arm's-length (819209)Forensic Accounting
- Assess whether umbrella attachment is too thin for the hazard (d05a57)Insurance Underwriting
See governed multi-model AI on your own prompt
Compare GPT-5, Claude, and Gemini side by side, with human review and a decision record built in.

